Blog
Modo Energy Series B investment, and ICEYE fundraise with partial realisation
Modo Energy Series B investment, and ICEYE fundraise with partial realisation
EQS-News: Cantourage appoints new member to its Management Board: Monique Jaqqam becomes Chief Financial Officer – Supervisory Board prolongs CEO Philip Schetter's mandate by five years
EQS-News: Cantourage appoints new member to its Management Board: Monique Jaqqam becomes Chief Financial Officer – Supervisory Board prolongs CEO Philip Schetter's mandate by five years
EQS-News: AFYREN and ESSE Skincare begin partnership to offer 100% natural cosmetic solutions with enhanced skincare performance
EQS-News: AFYREN and ESSE Skincare begin partnership to offer 100% natural cosmetic solutions with enhanced skincare performance
EQS-News: Nordex Group receives orders for 102 MW in France and Belgium
EQS-News: Nordex Group receives orders for 102 MW in France and Belgium
DKSH Submits Offer to Fully Take-Over its Subsidiary DKSH Holdings (Malaysia) Berhad and Aims to Delist the Company from the Malaysian Stock Exchange
DKSH Submits Offer to Fully Take-Over its Subsidiary DKSH Holdings (Malaysia) Berhad and Aims to Delist the Company from the Malaysian Stock Exchange
EQS-Adhoc: SURTECO GROUP SE: Adjustment of the forecast for 2025
EQS-Adhoc: SURTECO GROUP SE: Adjustment of the forecast for 2025
Fuller, Smith & Turner PLC: Transaction in own shares
Fuller, Smith & Turner PLC: Transaction in own shares
POS-Transaction in Own Shares
POS-Transaction in Own Shares
Cairn Homes Plc: Holding(s) in Company
Cairn Homes Plc: Holding(s) in Company
EQS-Adhoc: Airbus SE: Airbus reports share buybacks for week starting 1 December 2025
EQS-Adhoc: Airbus SE: Airbus reports share buybacks for week starting 1 December 2025
VALBIOTIS SA: Valbiotis announces completion of recruitment for the Cardio-Liver clinical study conducted with TOTUM•448 for metabolic liver diseases (MASLD)
VALBIOTIS SA: Valbiotis announces completion of recruitment for the Cardio-Liver clinical study conducted with TOTUM•448 for metabolic liver diseases (MASLD)
EQS-News: Bilfinger SE: Share Buyback
EQS-News: Bilfinger SE: Share Buyback
Form 8.3 - The Vanguard Group, Inc.: JTC plc
Form 8.3 - The Vanguard Group, Inc.: JTC plc
Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc
Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc
Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc
Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
Form 8.3 - The Vanguard Group, Inc.: Just Group plc
Form 8.3 - The Vanguard Group, Inc.: Just Group plc
Form 8.3 - The Vanguard Group, Inc.: NCC Group plc
Form 8.3 - The Vanguard Group, Inc.: NCC Group plc
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
EQS-Adhoc: Carl Zeiss Meditec AG: Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026
EQS-Adhoc: Carl Zeiss Meditec AG: Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026


